Navis Bio

The first wave of AI in biopharma was about designing better medicines. The next wave will focus on placing the right bets, such as identifying new indications, patient segments, or competitive advantages. We provide pharma companies with strategic market intelligence. Our solution systematically analyzes scientific literature, clinical trials, patents, and competitive intelligence to surface non-obvious insights - like untapped patient populations, optimal trial designs or whitespace in the competitive landscape. It is based on neuro-symbolic LLM pipelines, context engineering, and industry-specific ontologies to integrate scientific and business data.